As of 2025-05-18, the EV/EBITDA ratio of Union Korea Pharm Co Ltd (080720.KQ) is -4.07. EV/EBITDA ratio is calculated by dividing the enterprise value by the TTM EBITDA. 080720.KQ's latest enterprise value is 41,223.15 mil KRW. 080720.KQ's TTM EBITDA according to its financial statements is -10,137.76 mil KRW. Dividing these 2 quantities gives us the above 080720.KQ EV/EBITDA ratio.
Note: valuation result may not be accurate due to the company's negative EBITDA.
| Range | Selected | |
| Trailing P/E multiples | 6.7x - 10.5x | 8.6x |
| Forward P/E multiples | 6.4x - 9.7x | 7.9x |
| Fair Price | (11,124.80) - (14,944.10) | (13,060.08) |
| Upside | -508.2% - -648.4% | -579.3% |
| Date | EV/EBITDA |